In addition to substantial price reduction, Eli Lilly said it would launch on April 1 a new insulin product called Rezvoglar — a copycat version of Sanofi’s Lantus insulin.

Eli Lilly's Humalog, the prescribed insulin product Smith was taking, was $21 a vial when it hit the market in 1996. It has since jumped to $274.70, and will be cut to $66.40 when the new price ...

Eli Lilly & Co. will cut prices for some older insulin products later this year and immediately give more patients access to a cap on the costs they pay to fill prescriptions.

Eli Lilly's brand-name product, Humalog U-100, an insulin analogue (its generic name is insulin lispro), has a list price of $274.70 for a single 10 mL vial, for instance.

Eli Lilly cuts price of insulin, capping drug at $35 per month The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for ...

Drugmaker Eli Lilly says it will cut its insulin prices up to 70% and cap out-of-pocket costs for privately insured consumers at $35 a month.

Eli Lilly said it would cap the out-of-pocket cost of insulin at $35 per month. More than 8 million people with diabetes rely on insulin, which is notoriously expensive in the U.S.

Eli Lilly cuts insulin prices after years of outrage ... Yet, Lilly's most commonly prescribed insulin product, Humalog U-100, currently has a list price of $274.70 for a single 10 mL vial.

With FDA clearance secured for its Bluetooth-connected insulin dose-tracking technology, Eli Lilly is ready to pick up the tempo. The Big Pharma plans to begin rolling out its Tempo diabetes ...

New Delhi: There is excitement and hope in the insulin market the world over after U.S. based pharma giant Eli Lilly & Company on Monday announced results of its “successful” late-stage trial ...